Ronald Barliant serves as Executive at KALOBIOS PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Ronald Barliant has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 20, 2020 involved receiving (via award) 26,847 shares valued at $23.1K.
Ronald Barliant currently holds 449,351 shares of KALOBIOS PHARMACEUTICALS INC (KBIOQ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ronald Barliant has been a net neutral trader of KBIOQ stock. They have purchased $0 and sold $0 worth of shares.
Ronald Barliant's most recent insider trade was on May 20, 2020, when they sold 26,847 shares at $0.86 per share.
Get notified when new Form 4 filings are submitted
| $0.85 |
| Discretionary |
| May 31, 2019 | HGEN | $0 | Other | 236,499 | $N/A | Discretionary |
| Mar 29, 2019 | HGEN | $13.5K | Award | 10,000 | $1.35 | Discretionary |
| Jan 3, 2019 | HGEN | $13.5K | Award | 18,243 | $0.74 | Discretionary |
| Sep 28, 2018 | HGEN | $13.5K | Award | 21,094 | $0.64 | Discretionary |
| Aug 7, 2018 | HGEN | $13.5K | Award | 27,000 | $0.50 | Discretionary |
| Jun 30, 2016 | KBIOQ | $0 | Award | 93,786 | $N/A | Discretionary |